Identification of neuronal substrates of Rett syndrome and validation of therapies in preclinical models: a genomic, morphofunctional, and behavioural analysis in mouse models and patients

Reference:
GGP09196

Abstract:
Rett syndrome is a leading cause of mental retardation, second only to Down syndrome, which affects almost exclusively girls. This disease becomes manifest after a period of apparently normal development and causes growth retardation, severe psychomotor impairment and autistic behaviour. The majority of cases of Rett syndrome are caused by mutations in the gene encoding MECP2, a protein which binds DNA and regulates the expression of other genes, including that of brain-derived neurotrophic factor (BDNF), a major neurotrophin involved in brain development. No effective cure is available for this disease. We have gathered a multidisciplinary group made of people expert in molecular and cell biology, physiology and imaging, and Rett syndrome clinic to study the progression of the disease in patients and mouse models using the most advanced techniques. This should shed light on new alterations underlying the disease and could give to the clinician and the researcher markers to be used to monitor disease progression objectively and to assess the efficacy of clinical trials. A second aim of this project is a detailed analysis of a deficit in the mechanisms controlling protein synthesis in neurons that we began to characterized in the animal model. We plan to use this knowledge to test experimental therapies in mice.

PROJECT DETAILS 

beginning: 2009.

end: 2012.

Country of research: Italy

Counry of funding source: Italy

Funding organization: Telethon

Financing: PRIVATE FUNDERS – 482 200 €

hyperlink

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close